🔓
Sign in as a Member to unlock the full view of NVS. · Full hedge fund list, every line-item carveout, cabinet conflicts, and politicians-trading detail.
Become a Member$29.99/mo already a Member? Sign in →
NVS

Novartis AG

Sector: healthcareDrug Manufacturers - GeneralNYSEMarket Cap: $314.45B

Novartis AG is a multinational pharmaceutical company with a dominant political signal being $63.9M in 2024 doctor payments to its subsidiary Advanced Accelerator Applications, while showing zero federal contract, lobbying, or corporate insider activity.

Next filing → your inbox
Govt Dependence
0/100
Regulatory Density
85/100
Lobbying Intensity
0/100
Political Signal
NEUTRAL

BusinessWhat NVS does

Novartis AG operates as a global healthcare company, developing and commercializing prescription medicines, generics, and specialty therapies. Its revenue is derived from innovative pharmaceuticals, oncology drugs, biosimilars, and gene therapies. Key subsidiaries include Sandoz Inc., Novartis Pharmaceuticals Corporation, and Advanced Accelerator Applications.

12 months past · 3 months futureNVS activity timeline

$174$147$121 DecJan '26FebMarAprMayJunJulAugSepOctNovDecJan '27Feb ↓ PAST — recorded activity ↑ FUTURE — scheduled markups · pending votes TODAY · Nov 17 $168.62 hi $124.36 lo $160.20 CONGRESS 30 INSIDERS 0 13F FUNDS 30 BILLS 30 Kevin Hern (R) · Sale · 2026-08-27 Renaissance Technologies · - $185M · 2025-12-31Renaissance Technologies · - $170M · 2026-03-31Citadel Advisors · + $162M · 2026-06-30Citadel Advisors · + $126M · 2026-03-31Millennium Management · + $125M · 2026-06-30Renaissance Technologies · - $124M · 2026-06-30Renaissance Technologies · - $94M · 2026-09-30Citadel Advisors · + $61M · 2025-12-31Point72 Asset Management · OPENED $51M · 2026-03-31Point72 Asset Management · - $50M · 2026-06-30AQR Capital Management · + $44M · 2026-06-30AQR Capital Management · OPENED $36M · 2026-03-31 HR.2001 · passed_one · 2026-07-21 MARKUP · Senate Veterans' Affairs · 2026-11-18MARKUP · Senate Finance · 2026-11-18MARKUP · Senate Health, Education, Labor, and Pensions · 2026-11-18MARKUP · Senate Budget · 2026-11-18MARKUP · Senate Veterans' Affairs · 2026-11-18
Congress
buy sell
Insider · Form 4
open-market buy
Hedge fund · 13F
opened + added − trimmed closed holds
Bills
past action (this ticker) upcoming markup (sector) ★ carveout (this ticker)
250 trading days · 1 congressional trades shown · 0 insider buys · 12 13F filings · 1 past bill actions · 5 upcoming markups

Lifetime Government AwardsNVS federal contracts

NVS doesn't hold direct federal contracts.

Verified via USASpending.gov: $0 reported in direct prime-contract awards. Companies in this position typically sell federal services indirectly through prime contractors and integrators (e.g., Lockheed Martin, Booz Allen, Microsoft Azure) or through commercial channels that don't appear in USASpending data.

Smart Money · 13F HoldingsHedge funds holding NVS

$486.2M
Total NVS held by tracked 13F funds
7
Funds with NVS positions
Citadel Advisors $162M +25% 2026-06-30
Millennium Management $125M +355% 2026-06-30
Renaissance Technologies $94M -16% 1 overlap 2026-09-30
Point72 Asset Management $50M -5% 2026-06-30
AQR Capital Management $44M +20% 2026-06-30
D.E. Shaw & Co. $8M -28% 2026-06-30
Two Sigma Investments $2M -48% 2026-06-30

Politicians Trading NVSMembers of Congress with recent NVS positions

3 politicians traded NVS across 24 disclosed transactions totaling $551K (last 730 days). Greed score = composite of trade frequency, volume & recency across the politician's entire history (not just NVS). 0-30 LOW · 30-60 MID · 60+ HIGH.

Congressional TradesWho in Congress is trading NVS

2026-08-27 Kevin Hern R-Oklahoma · house Sale $15,001 - $50,000
2025-10-30 Lisa C. McClain R-Michigan · house sale $1,001 - $15,000
2025-10-30 Lisa C. McClain R-Michigan · house purchase $1,001 - $15,000
2025-10-31 Lisa C. McClain R-Michigan · house sale $1,001 - $15,000
2025-10-30 Lisa C. McClain R-Michigan · house Sale $1,001 - $15,000
2025-10-30 Lisa C. McClain R-Michigan · house Purchase $1,001 - $15,000
2025-10-31 Lisa C. McClain R-Michigan · house Sale $1,001 - $15,000
2025-09-25 Lisa C. McClain R-Michigan · house Sale (Partial) $1,001 - $15,000
2025-09-11 Lisa C. McClain R-Michigan · house purchase $1,001 - $15,000
2025-09-25 Lisa C. McClain R-Michigan · house sale $1,001 - $15,000
2025-09-11 Lisa C. McClain R-Michigan · house Purchase $1,001 - $15,000
2025-09-25 Lisa C. McClain R-Michigan · house Sale $1,001 - $15,000
30+ trades on file · most recent 2026-09-25

Corporate Insiders · Form 4What CEOs, CFOs, and directors are doing with their own stock

No Form 4 activity recorded in the last 180 days.

Bills Affecting NVSLive legislation impacting this stock

Political ProfileWhere NVS sits in Washington

[object Object]

STRUCTURAL: High regulatory density (score 85) from healthcare sector exposure and $63.9M in doctor payments (get_political_influence.doctor_payments). EVIDENTIARY: No federal contracts (get_government_precedent.federal_contracts_summary is null), zero lobbying spend, zero corporate insider buys in 180 days (get_corporate_insider_signal.total_buys: 0), and no executive branch holdings. Net: Significant structural regulatory interface but no evidentiary political engagement or trading signals.

Regulatory ExposureThreats & opportunities

Regulatory threats

  • Heightened scrutiny of physician payments under transparency laws
    CMS/Open Payments
    "get_political_influence.doctor_payments shows $63.9M in 2024 payments from Advanced Accelerator Applications."

Regulatory opportunities

  • Potential for favorable reimbursement policies for radiopharmaceuticals and gene therapies
    CMS
    "High-value doctor payment program for Advanced Accelerator Applications ($63.9M) indicates commercial engagement in specialized therapeutic areas."
Member intelligence layer

Live signals + predictions for NVS — for Founders

The free page above gives you the public record. Members see the real-time intelligence layer on top of it:

Become a Founder · $29.99/mo Locked rate forever · cancel anytime

Frequently AskedAbout NVS & political exposure

Does Novartis AG (NVS) hold federal contracts?
No direct prime contracts reported in USASpending.gov for Novartis AG. Companies in the semiconductor and AI hardware sectors often sell to the federal government via prime contractors and cloud resellers (Microsoft Azure, AWS, Lockheed Martin systems integration) rather than as direct primes.
Has Congress traded NVS stock?
212 congressional trades by 25 unique members of Congress, most recently on 2026-08-27. See the Congressional Trading panel for politician-by-politician breakdown.
What is NVS political risk profile?
Government dependence: 0/100. Lobbying intensity: 0/100. Political signal: neutral. Donor party split: R 0% / D 0%.
How does GovGreed track NVS political activity?
GovGreed integrates STOCK Act congressional trade disclosures, FEC contributions, OGE executive-branch disclosures, USASpending federal contracts, Senate LDA lobbying filings, and SEC Form 4 corporate insider trades into a single queryable graph. NVS data is updated daily from these official federal sources.